🇺🇸 FDA
Patent

US 7855190

Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

granted A61KA61K31/56A61K31/567

Quick answer

US patent 7855190 (Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration) held by TEVA WOMEN'S HEALTH, INC. expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA WOMEN'S HEALTH, INC.
Grant date
Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K31/56, A61K31/567, A61P, A61P11/06